A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemaciclib) Among Breast Cancer Patients in China Verzenios® (Abemaciclib) Among Breast

Clinical trial NCT05267327 · UNKNOWN

Trial details

NCT number: NCT05267327
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: UNKNOWN
Study type: OBSERVATIONAL

The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks

Start date: 2022-03-01
Primary completion: 2024-06-01
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.